+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq



Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq



Genome Research 20(10): 1451-1458



Candida albicans is the major invasive fungal pathogen of humans, causing diseases ranging from superficial mucosal infections to disseminated, systemic infections that are often lifethreatening. We have used massively parallel high-throughput sequencing of cDNA (RNA-seq) to generate a high-resolution map of the C. albicans transcriptome under several different environmental conditions. We have quantitatively determined all of the regions that are transcribed under these different conditions, and have identified 602 novel transcriptionally active regions (TARs) and numerous novel introns that are not represented in the current genome annotation. Interestingly, the expression of many of these TARs is regulated in a condition-specific manner. This comprehensive transcriptome analysis significantly enhances the current genome annotation of C. albicans, a necessary framework for a complete understanding of the molecular mechanisms of pathogenesis for this important eukaryotic pathogen.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269968

Download citation: RISBibTeXText

PMID: 20810668

DOI: 10.1101/gr.109553.110


Related references

Candida albicans, a major human fungal pathogen. Journal of Microbiology 49(2): 171-177, 2011

Genetics of Candida albicans, a diploid human fungal pathogen. Annual Review of Genetics 41: 193-211, 2007

Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryotic Cell 9(7): 991-1008, 2010

Human fungal pathogen Candida albicans in the postgenomic era: an overview. Expert Review of Anti-Infective Therapy 7(1): 121-134, 2009

Experimental annotation of the human pathogen Candida albicans coding and noncoding transcribed regions using high-resolution tiling arrays. Genome Biology 11(7): R71, 2010

Rac1 dynamics in the human opportunistic fungal pathogen Candida albicans. Plos One 5(10): E15400, 2011

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans. Annals of Clinical Microbiology and Antimicrobials 14: 32, 2016

An improved transformation protocol for the human fungal pathogen Candida albicans. Current Genetics 42(6): 339-343, 2003

Oxidative stress responses in the human fungal pathogen, Candida albicans. Biomolecules 5(1): 142-165, 2015

A novel type 2C protein phosphatase from the human fungal pathogen Candida albicans. FEBS Letters 509(1): 142-144, 2001

Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans. Brazilian Journal of Microbiology 44(3): 855-859, 2015

CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans. Journal of Visualized Experiments 2018(141), 2018

Rad6p represses yeast-hypha morphogenesis in the human fungal pathogen Candida albicans. Molecular Microbiology 35(5): 1264-1275, 2000

Functional analysis of apoptosis-inducing factor in the human fungal pathogen Candida albicans. Hong Kong Medical Journal 22 Suppl 7(6): 30-33, 2016

Functional characterization of the PP2C phosphatase CaPtc2p in the human fungal pathogen Candida albicans. Yeast 27(9): 753-764, 2010